Financial Disclosure

HomeAboutIndustry Resources ▶ Financial Disclosure
Financial Disclosure

ATS Compliance with the Council of Medical Specialty Societies
Code for Interactions with Companies

 

The American Thoracic Society (ATS) Board of Directors adopted the Council of Medical Specialty Societies Code for Interactions with Companies (CMSS Code) in October 2010.  The CMSS Code Standard 2.2 states:

“Societies will disclose Company support (at a minimum Educational Grants, Corporate Sponsorships, Charitable Contributions, and support of Research Grants), making this information available to their members and the public.”

In compliance with the CMSS Code, the ATS is pleased to disclose annually all financial and in-kind relationships with companies that support or participate in ATS activities, which helps make what we do possible. Below, please find disclosures for the period of January 1, 2019 to December 31, 2019. Companies are listed alphabetically by level.

Charitable contributions and educational grants in support of the ATS Research Program that are made during 2019 are summarized on the Research Program’s website.

 


Educational Grants (Accredited and Independent Non-Accredited Education):

$250,000 to $499,999:

  • Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech

$100,000 to $249,999:

  • Actelion Pharmaceuticals US, Inc.; Bayer Healthcare Pharmaceuticals; GlaxoSmithKline; Vertex Pharmaceuticals, Inc.

$75,000 to $99,999:

  • Insmed, Inc.

$50,000 to $74,999:

  • AstraZeneca Pharmaceuticals

$25,000 to $49,999:

  • Mallinckrodt Pharmaceuticals

$10,000 to $25,000:

  • Boston Scientific Corporation; Novartis Pharmaceuticals Corporation; Olympus Corporation of the Americas; Sanofi Genzyme Regeneron; United Therapeutics Corporation

 

Exhibit, Industry Programs and International Conference Advertising Revenue:

$175,000 and above:

  • Boehringer Ingelheim Pharmaceuticals, Inc

$100,000 to $174,999:  

  • Actelion Pharmaceuticals US, Inc.; Genentech, Inc; GlaxoSmithKline; Regeneron Pharmaceuticals/Sanofi Genzyme; Sunovion Pharmaceuticals, Inc.

$50,000 to $99,999:

  • AstraZeneca; Biofire Diagnostics, LLC; Teva Pharmaceuticals

$20,000 to $49,999:  

  • 4Dx; Boston Scientific Corporation; Fisher & Paykel Healthcare; Genentech/Novartis; Insmed Incorporated; INTUITIVE; Medtronic; Novartis Pharmaceuticals; Olympus Corporation of the Americas; ResMed; United Therapeutics Corporation; Vertex Pharmaceuticals, Inc.

$10,000 to $19,999:

  • Allergan USA, Inc.; Bayer US; Boston Medical Products/Novatech; FUJIFILM Medical Systems U.S.A., Inc.; Gilead Sciences, Inc.; Grifols USA, LLC; Hill-Rom; International Biophysics; Jazz Pharmaceuticals; Mallinckrodt Pharmaceuticals; MGC Diagnostics; Morgan Scientific, Inc.; Mylan, Inc.; ndd Medical Technologies; Phillips Respironics, Inc.; Pulmonx Corp; Takeda; Ventec Life Systems; Veran Medical Technologies; Vitalograph, Inc.; Vyaire Medical

$1 to $9,999:

  • 3D Systems, Healthcare; Acceleron Pharma; Aerogen; Allergy and Asthma Network; Alliance Tech Medical, Inc.; Alpha-1 Foundation; Altavant Sciences; ALung Technologies; AMBU; American Association of Respiratory Care (AARC); American Board of Internal Medicine; American College of Chest Physicians (CHEST); American Lung Association in Texas; American Thoracic Society; Ardent Health Services; ARDS Foundation; Asian Pacific Society of Respirology (APSR); Asociacion Argentina de Medicina Respiratoria (AAMR); Asociacion Latinoamericana de Torax (ALAT); Associates of Cape Cod, Inc.; Association of Pulmonary Advanced Practice Providers; Asthma and Allergy Foundation of America; Auris Health; AyuVis Research; B. Braun Interventional Systems, Inc.; Baylor Scott & White Health; BD; Bellerophon Therapeutics; Biodesix, Inc.; Biogen; BleepSleep; Bristol-Myers Squibb/Pfizer; Body Vision Medical; Bosch Healthcare Solutions GmbH; BRAEBON Snoring & Sleep Apnea; Brazilian Thoracic Society; Breathe Technologies; Broncus Medical; Bruker Biospin; BTG; Canadian Thoracic Society; CDC National Center for Environmental Health; Centers for Disease Control and Prevention - Division of Tuberculosis Elimination; Children’s Hospital of Michigan; Children's Interstitial & Diffuse Lung Disease Foundation; Christus Health; Cincinnati Children's Hospital; Circassia Pharmaceuticals; Clement Clarke International; CMI Health Inc.; Cohero Health; Contec Medical Systems CO, LTD; Cook Medical; COPA Syndrome Foundation; Coreline Soft Ltd.; Covalon Technologies AG; CRC Press/Taylor Francis Group; Data Sciences International; Dynaris; Eastern Pulmonary Conference; ECO Medics - ECO Physics; Egyptian Pediatric Pulmonary Society; Elsevier; EMMS; Envision Physician Services; ERBE USA; eResearch Techology Inc. (ERT); European Respiratory Society; FDA Center for Tobacco Products; FibroGen, Inc; Fidelta, LTD; FLUIDDA NV; Foundation for Sarcoidosis Research; FutureMed; Ganshorn LLC; FLUIDDA NV; Foundation of Sarcoidosis Research; Fujifilm SonoSite; FutureMed; Galapagos NV; Ganshorn LLC; GCE Healthcare; Great Lakes Dental Technologies; Hans Rudolph, Inc; HCMED Innovations; Healthup | AioCare; Hermansky Pudlak Syndrome Network, Inc.; Hexoskin; Houston Methodist J.C. Walter JR Transplant Center; Huger Medical Instrument Co. Ltd.; ID by DNA, Inc.; Imbio, LLC; Indian Chest Society; Infinity Massage Chairs; Inspire Medical Systems; International Institute for the Advancement of Medicine; International Society for Aerosols In Medicine; International Union Against Tuberculosis and Lung Disease; Irish Thoracic Society; Itamar Medical; Japanese Respiratory Society; Kaiser Permanente; Konica Minolta; Kreg Therapeutics; La Jolla Pharmaceuticals Company; Level-Ex; Lung Transplant Foundation; LUNGevity Foundation; Lymol Medical Corporation; Marshfield Clinic Health System; Masimo; Maxor Specialty; Mayne Pharma; McGuff Pharmaceuticals; MedEd On The Go; MedQIA; Merit Medical Endotek; Methapharm Inc.; MIR Medical International Research USA; Monaghan Medical Corporation; Monitored Therapeutics; Mount Sinai Health System; Munson Healthcare; National Board for Respiratory Care; National Board of Echocardiography, Inc.; National Death Index; National Disease Research Interchange; National Heart Lung and Blood Institute; National Institute of Environmental Health Science (NIEHS); National Jewish Health; Neilmed Pharmaceuticals; NeuWave/ Johnson & Johnson; Northwell Health; Northwest Seminars; Nova Biomedical; Novabiosis; NTM Info & Research, Inc.; Nuvoair; Oncimmune USA LLC; Optellum Ltd.; Owlstone Medical Ltd; Pan African Thoracic Society (PATS); Passy Muir, Inc.; patientMpower; PCD Foundation; Pediatric Search Partners; Penn State Health; PerkinElmer; PERT Consortium; PF Warriors; Polarean, Inc.; PracticeLink; Praedicare; Propeller Health; Provider Solutions + Development; Public Health Foundation of India; Pulmonary Fibrosis Foundation; Pulmonary Hypertension Association; Pulmonary Wellness Online; PulmOne USA Inc.; RB (Reckitt Benckiser Pharmaceuticals); Reata Pharmaceuticals; resTORbio; Rocket Medical; Sanostec Corporation; Santhera Pharmaceuticals; Savara, Inc; SCIREQ - an emka TECHNOLOGIES company; SCL Health; Scleroderma Foundation; SEOIL Pacific Corp.; SomnoMed, Inc.; Spire Health; St. Joseph Hospital & Medical Center; Stemcell Technologies, Inc.; SynsorMed; Taiwan Society of Pulmonary Critical Care Medicine; Temple Lung Center; The Intensivist Company; The JAMA Network; The Lam Foundation; Thirona; Thoracic Society of Australia and New Zealand; THORASYS Thoracic Medical Systems Inc.; TSI Healthcare; Tuberous Sclerosis Alliance; Turkish Thoracic Society (TTS); U.S. Acute Care Solutions; U.S. EPA's National Air and Energy Research Program; United States Navy Recruiting Command; UMPC; UreSil LLC; US Army Dallas Medical Recruiting Station; Vathin Medical Co. Ltd.; Veracyte; Wolters Kluwer Health

 

Collaborative Educational Programs:

$200,000 to $500,000+:

  • Boehringer Ingelheim Pharmaceuticals Inc.; GlaxoSmithKline

$100,000 to $199,999:

  • None

$1 to $99,999:

  • American Academy of Family Physicians

 

ATS 2019 Corporate Membership Program:

$50,000:

  • Actelion Pharmaceuticals US, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech; GlaxoSmithKline; Novartis Corporation; Sanofi Genzyme Regeneron; Sunovion Pharmaceuticals; Teva Respiratory; Theravance Biopharma; United Therapeutics Corporation

$35,000:  

  • Bayer Healthcare; Insmed, Inc.; Mallinckrodt Pharmaceuticals; Merck & Co.; Mylan; Vertex Pharmaceuticals, Inc.

$10,000:

  • Bellerophon Therapeutics; Boston Scientific Corporation; Circassia Pharmaceuticals; Fisher&Paykel Healthcare; Galapagos NV; Shionogi Inc.; Verona Pharma

$5,0000:

  • Bristol-Myers Squibbs; Pieris Pharmaceuticals, Inc.; Pulmonx; Santhera Pharmaceuticals; Veracyte; Vitalograph; Vivus

 

ATS Journal and Other Non-Conference Advertising:

$200,000 and above:

  • GlaxoSmithKline; Mylan

$50,000 to $200,000:

  • AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc; Genentech, Inc.; Gilead Sciences; Insmed, Inc.; Veracyte

$35,000 to $49,999:

  • Merck & Co.; New York- Presbyterian

$15,000 to $34,999:

  • None

$1 to $14,999:

  • Airway Management Education; Boise VA Medical Center; Brigham & Women’s Hospital; Children's Hospital of Pittsburgh of UPMC -  Barbara Petrick; Cincinnati Children’s Hospital; Eastern Pulmonary Conference; Galapagos NV; Johns Hopkins University; Maimonides Children's Hospital; Medtelligence; Metro Health; National Jewish Health;  Northwestern Medicine; Rochester Regional Health; Roswell Park Comprehensive Care Center; Stemcell Technologies; Temple University Health System (Lung Center); United Therapeutics; University of Pittsburgh; University of Rochester Medical Center - Christine Crist; University of Washington Medical Center; University of Wisconsin- Pulmonary and Critical Care; UMPC Montefiore Hospital; Verathon

 

ATS Journal Non-Advertising Revenue (Reprints)

$30,000 and above:

  • Boehringer Ingelheim Pharmaceuticals, Inc.

$15,000 to $29,999:

  • GlaxoSmithKline; Life Science Publishing Co.; Reprints Unlimited

$1 to $15,000:

  • Elsevier; CSL Behring; Dove Medical Press; Home Medical Equipment ltd (HME); IDEMM Farma S.L; Novartis Pharmaceuticals;

 

Charitable Contributions:

  • No Disclosures

 

In Kind (Non-Monetary) Support (such as loan of equipment used in hands-on learning courses planned and controlled by the ATS):

  • Ambu; Becton, Dickinson and Company; Blue Phantom; Boston Scientific Corporation; CAE Healthcare: Clement Clarke; Cook Medical; Edwards LifeSciences LLC; ERBE USA, Inc.; Fisher & Paykel Healthcare; FujiFilm SonoSite, Inc.; Getinge; GlaxoSmithKline; Hill-Rom, Inc.; MCG Diagnostics; Medtronic; Merit Medical Endotek; Mindray; Monaghan Medical Corporation; Mylan Pharmaceutical Inc.; ndd Medical Technologies, Inc.; Olympus Corporation of the Americas; Philips; Philips Respironics; ResMed; SunMed; Sunovion Pharmaceuticals, Inc.; Teleflex Incorporated; Teva Pharmaceuticals; Verathon; Vyaire Medical;;

 

All questions about the Society’s interactions with industry should be directed to Michelle Turenne – Chief of Development (mturenne@thoracic.org).